Victoria's Secret's board defended its position against Brett Blundy's proxy assault, dismissing the Australian billionaire's campaign to oust two directors, including chair Donna James, as a distraction from operational priorities.
Blundy, who built a significant stake in the intimate apparel retailer through his investment vehicle Bluebell Capital Partners, initiated a proxy fight aimed at reshaping the board's composition. His slate targets James along with another director, seeking to install nominees aligned with his vision for the company's strategic direction.
The board countered that Blundy's public campaign diverts attention from the retailer's turnaround efforts under current leadership. James, who took the chair role as Victoria's Secret navigated post-pandemic recovery and shifting consumer preferences toward comfort-focused lingerie, has stewarded the brand through considerable transformation.
The proxy battle reflects broader tensions within Victoria's Secret's ownership structure. The company separated from parent L Brands in 2020, establishing itself as an independent public entity. Since then, the brand has worked to modernize its image, moving away from the "Angel" model era toward inclusive sizing and body-positive messaging under Chief Executive Officer Amy Hauk.
Blundy's intervention suggests investor frustration with the pace of turnaround progress. The activist investor typically pursues board changes when conventional shareholder engagement fails to produce desired results. His push at Victoria's Secret signals belief that current leadership lacks the strategic clarity or execution capability needed to unlock shareholder value.
The board's push-back indicates entrenchment. Shareholders will ultimately decide the contest's outcome at the company's next annual meeting, where they'll vote on board composition. The outcome will determine whether James and her ally retain their seats or if Blundy gains influence over the retailer's strategic agenda, including decisions around marketing direction, product development, and financial performance targets.
THE TAKE
